NEWS
Results to be proud of: increase of Norameda’s profit by 130 per cent
Despite the challenging market conditions, Norameda's 2023 performance was a testament to its resilience. The company not only managed to maintain its revenue at a healthy 7% increase compared to 2022 (28.3m vs 26.3m) but also saw a significant 130% growth in profits....
New Price List for Reimbursable Medicines in Lithuania – Norameda’s Assessment
The updated price list for reimbursable medicines came into force in Lithuania in July and has received mixed reactions. Ministry of Health's Perspective According to the Ministry of Health of Lithuania, the new mechanism for selecting reimbursable medications was...
World Sleep Day – let’s talk about Narcolepsy
Why is it important to talk today? It has a profound impact on the lives of sufferers but is also very difficult to diagnose. For example, according to global statistics, about 500-600 people are suffering from Narcolepsy in Lithuania, but only 30 are currently...
Good news from Norameda on the International Rare Disease Day
Until 2024, the Norameda Special Care Medicine Department has been actively working with two main rare diseases: Alpha-mannosidosis and Hereditary Leber optic Neuropathy. This year, Norameda introduced a new option in treating Fabry disease and is entering a new field...